Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00380302 | Activity of AVE1625 in Mild to Moderate Alzheimer's Patients. | PHASE1 | COMPLETED | 162 | — | — | Sep 1, 2006 | Jul 1, 2007 | Dec 19, 2008 | 5 | United States, France +3 |
| Name | Type | Description |
|---|---|---|
| AVE1625 | DRUG | - |
Inclusion Criteria: * The diagnosis of Alzheimer's disease * Recent brain image(Computerized Axial Tomographic Scan -CAT scan or Magnetic Resonance Imaging - MRI) * Mild to moderate range of disease; not too severe Exclusion Criteria: * Severe or unstable medical diseases * Neurological disorder ...